Trexquant Investment LP Has $10.39 Million Stock Position in Alignment Healthcare, Inc. $ALHC

Key Points

• Trexquant Investment LP increased its stake in Alignment Healthcare by 159%, owning approximately 558,177 shares valued at $10.39 million as of the end of the most recent quarter.
• Analysts have mixed views on Alignment Healthcare, with brokerages varying from a "strong-buy" rating to a "hold" rating, leading to an average rating of "Moderate Buy" and a consensus target price of $18.83.
• Alignment Healthcare reported a 49% year-over-year increase in revenue, with a quarterly earnings per share of $0.07, surpassing analysts' expectations of a loss.

Trexquant Investment LP lifted its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 159.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 558,177 shares of the company's stock after purchasing an additional 342,691 shares during the quarter. Trexquant Investment LP owned approximately 0.28% of Alignment Healthcare worth $10,393,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of ALHC. MCF Advisors LLC boosted its position in shares of Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after acquiring an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ bought a new position in Alignment Healthcare during the first quarter worth $42,000. Amalgamated Bank increased its position in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after acquiring an additional 616 shares during the period. Tower Research Capital LLC TRC boosted its holdings in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after purchasing an additional 6,286 shares during the period. Finally, Voloridge Investment Management LLC bought a new stake in Alignment Healthcare in the 4th quarter valued at $189,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC traded up $0.28 during mid-day trading on Tuesday, hitting $16.64. 3,583,120 shares of the stock were exchanged, compared to its average volume of 3,005,335. Alignment Healthcare, Inc. has a twelve month low of $8.65 and a twelve month high of $21.06. The stock's fifty day simple moving average is $13.98 and its two-hundred day simple moving average is $15.37. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market cap of $3.30 billion, a P/E ratio of -59.43 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. During the same quarter in the previous year, the company posted ($0.13) earnings per share. Alignment Healthcare's quarterly revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a report on Monday, August 25th. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Zacks Research raised shares of Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Finally, Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price target for the company from $9.00 to $13.00 in a report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $18.83.

Insider Buying and Selling

In other Alignment Healthcare news, CEO John E. Kao sold 180,000 shares of the firm's stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the sale, the chief executive officer owned 1,553,100 shares in the company, valued at approximately $20,827,071. This trade represents a 10.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Hyong Kim sold 24,800 shares of the firm's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $16.00, for a total transaction of $396,800.00. Following the completion of the sale, the insider owned 447,367 shares of the company's stock, valued at $7,157,872. The trade was a 5.25% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 636,185 shares of company stock valued at $9,235,468 in the last ninety days. 6.60% of the stock is owned by corporate insiders.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.